Symbol="MNKD"
AssetType="Common Stock"
Name="MannKind Corp"
Description="MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California."
CIK="899460"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1384963000"
EBITDA="-17257000"
PERatio="None"
PEGRatio="-0.23"
BookValue="-0.971"
DividendPerShare="0"
DividendYield="0"
EPS="-0.28"
RevenuePerShareTTM="0.601"
ProfitMargin="-0.3"
OperatingMarginTTM="-0.15"
ReturnOnAssetsTTM="-0.0496"
ReturnOnEquityTTM="0"
RevenueTTM="158121000"
GrossProfitTTM="42273000"
DilutedEPSTTM="-0.28"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.573"
AnalystTargetPrice="6.7"
TrailingPE="-"
ForwardPE="303.03"
PriceToSalesRatioTTM="16.5"
PriceToBookRatio="-"
EVToRevenue="18.71"
EVToEBITDA="-22.02"
Beta="1.529"
num_52WeekHigh="5.75"
num_52WeekLow="2.91"
num_50DayMovingAverage="4.366"
num_200DayMovingAverage="4.491"
SharesOutstanding="264306000"
DividendDate="2017-03-03"
ExDividendDate="None"
symbol="MNKD"
open="5.20"
high="5.26"
low="5.04"
price="5.05"
volume="3490731.00"
latest_trading_day="2023-08-16"
previous_close="5.24"
change="-0.19"
change_percent="-3.6260%"
aroon_positive_momentum_days="51"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="3024622"
Change_recent_avg="0.01"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_negative_thumbnail_id_2="508"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="971"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0133.jpeg"
image_positive_thumbnail_id_2="645"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
